IL5 and chronic rhinosinusitis without nasal polyps: Therefore, it is discussed as a possible therapeutic target in NP and studies with anti-IL-5 monoclonal antibodies show auspicious results [28]. In conclusion, our results indicate a down-regulation of TH2 lymphocytes in CRSsNP.